Morgan Stanley filings document the company’s financial services business, capital structure, governance and material events. The record includes 8-K reports for current events, proxy materials for annual meeting and shareholder voting matters, and securities listings covering common stock, depositary preferred shares and medium-term notes associated with Morgan Stanley Finance LLC.
Filings also disclose governance procedures, registered security classes, NYSE listing information, preferred stock series, debt-security registration matters and formal status changes such as a Form 25 notice for removal of a listed note class from exchange registration.
Morgan Stanley Finance LLC is offering principal-at-risk, auto-callable structured notes linked to the VanEck® Semiconductor ETF with a stated principal amount of $1,000 per security and an original issue date of June 22, 2026. The notes may be automatically redeemed on the first determination date June 21, 2027 for an early redemption payment of $1,287.50 if the closing level of the underlier is at or above the call threshold.
If not redeemed early, maturity is June 22, 2029 with payoff mechanics that pay upside at maturity when the final level exceeds the initial level (participation rate 150%), return principal if the final level is at or above 70% of the initial level, or deliver a loss proportional to the underlier decline if the final level is below 70% of the initial level. All payments are unsecured and subject to the issuer’s and guarantor’s credit risk.
Morgan Stanley Finance LLC is offering principal-at-risk, contingent income auto-callable securities linked to the common stock of Amazon.com, Inc., fully and unconditionally guaranteed by Morgan Stanley. Each security has a $1,000 stated principal amount and an issue price of $1,000.
The securities pay a contingent coupon at an annual rate of 16.50% only if the closing level of the underlier on each observation date is at or above the coupon barrier level (set at 80% of the initial level). They are subject to automatic early redemption if the closing level on any redemption determination date is at or above the call threshold (set at 100% of the initial level). If not redeemed, maturity is August 1, 2029 with a final observation on July 27, 2029; if the final level is below the downside threshold (also 80% of initial level), investors suffer principal losses pro rata and could lose their entire investment. All payments are subject to Morgan Stanley’s credit risk.
Morgan Stanley Finance LLC offers a Preliminary Pricing Supplement for Buffered PLUS securities due June 27, 2029, fully guaranteed by Morgan Stanley. Each security has a $1,000 stated principal amount. The securities provide a 124% leveraged upside on the worst performing of the Dow Jones Industrial and the S&P 500 over the term, a 15% buffer and a 15% minimum payment at maturity. The estimated value on the pricing date is approximately $984.60 per security; all payments are subject to issuer and guarantor credit risk.
Morgan Stanley Finance LLC priced a contingent income, principal-at-risk note due June 13, 2029 linked to the worst performing of the S&P 500, Dow Jones Industrial, Nasdaq-100 and Russell 2000 indices.
The securities have a stated principal of $1,000 per security, a contingent coupon rate of 9.30% per annum, an estimated value on the pricing date of approximately $984.40, and downside threshold/coupon barrier levels set at 70% of each index's initial level. Coupons pay only if every underlier is at or above its coupon barrier on each observation date; at maturity investors either receive principal or a performance-adjusted payout based on the worst performing underlier.
Morgan Stanley Finance LLC offers Principal-at-Risk PLUS securities linked to the common stock of UnitedHealth Group Incorporated. The securities pay no interest, have a $1,000 stated principal amount per security, mature on June 14, 2027, and use an initial level of $406.57 (strike date June 8, 2026).
They provide a 300% leverage factor on upside subject to a maximum payment of $1,355.50 per security (135.55% of principal). If the final level is below the initial level, holders lose principal on a pro rata basis (1% loss for each 1% decline). Estimated value on the pricing date was approximately $979.50. All payments are subject to Morgan Stanley Finance LLC and Morgan Stanley credit risk.
The issuer Morgan Stanley Finance LLC, guaranteed by Morgan Stanley, is offering principal‑at‑risk PLUS securities linked to the common stock of Elevance Health, Inc.. Each security has a stated principal amount of $1,000, an initial level of $418.15, a leverage factor of 300% and a maximum payment at maturity of $1,370.50 (137.05% of principal). The securities mature on June 14, 2027 with an observation date of June 9, 2027. At maturity, investors receive the stated principal plus 300% of appreciation up to the cap, or suffer a 1% principal loss for each 1% decline in the underlier; there is no minimum payment. Estimated value on the pricing date was approximately $975.90 per security. All payments are subject to issuer and guarantor credit risk.
Morgan Stanley Finance LLC offers principal-at-risk structured notes linked to the worst performing common stock of Elevance Health, Inc. and UnitedHealth Group Incorporated, due June 13, 2029. Each security has a stated principal amount of $1,000 and an estimated value on the pricing date of approximately $959.50. The notes feature an automatic early redemption on the first determination date (June 22, 2027) if both underliers are at or above their call threshold levels (ELV $418.15; UNH $406.57), producing an early redemption payment of $1,527.50 per security. At maturity, if not auto‑redeemed, payoffs depend on the worst performing underlier: upside participation at a 150% participation rate if both final levels exceed initial levels; return of principal if final levels remain above 90% of initial; or a pro rata loss equal to the percentage decline of the worst performing underlier, which could result in a total loss of principal.
Morgan Stanley Finance LLC is offering structured, principal‑at‑risk notes due September 13, 2027 linked to the S&P 500® Index. Each security has a $1,000 stated principal amount and a fixed upside payment of $86.50 (8.65%) payable at maturity if the final level is at or above the buffer level.
If the final level is below the buffer level (set at 80% of the initial level), investors lose 1% of principal for each 1% decline beyond the 20% buffer; the minimum payment at maturity is 20% of principal. All payments are unsecured and subject to Morgan Stanley’s credit risk; estimated value on the pricing date is approximately $991.50 per security.
Morgan Stanley Finance LLC priced Principal-at-Risk, auto-callable structured notes due June 12, 2031 linked to a weighted basket (MSCI EAFE, MSCI Emerging Markets, S&P 500 Futures Excess Return). Each security has a $1,000 stated principal amount and a 275% participation rate for upside if held to maturity.
The securities can be automatically redeemed on the first determination date (June 10, 2027) if the underlier closing level is ≥ the call threshold (100), producing an early redemption payment of $1,150. At maturity, outcomes depend on the final level relative to the initial level (100) and the downside threshold (80), including potential loss of principal down to zero.
Morgan Stanley Finance LLC is offering principal-at-risk, contingent income auto-callable securities linked to the common stock of Archer-Daniels-Midland Company. Each security has a $1,000 stated principal amount and a contingent coupon of 14.25% per annum payable only if the underlier meets observation-date barriers. The securities can be automatically redeemed on scheduled redemption determination dates if the underlier is at or above the call threshold; otherwise they remain outstanding to maturity on June 13, 2029 with final payoff tied to the final closing level. If the final level is below the downside threshold, investors suffer a proportional loss of principal and could lose their entire investment. All payments are subject to Morgan Stanley's credit risk.